Skip to main content
Midas Edge

ETHZilla Corp

For the period ended Sep 30, 2025. Filed Nov 14, 2025.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Sep 30, 2025 · Filed Nov 14, 2025

FRMM$2.88-5.3%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Item 6. Exhibits

The following exhibits are filed herewith or incorporated by reference herein:

Incorporated by Reference
Exhibit Number · Description of Exhibit · Filed/ Furnished Herewith · Form · Exhibit · Filing Date/Period End Date · File Number
1.1Sales Agreement, dated August 13, 2025, by and between 180 Life Sciences Corp. and Clear Street LLC8-K1.18/13/2025001-38105
1.2Amended and Restated Sales Agreement, dated August 22, 2025, by and between ETHZilla Corporation and Clear Street LLC8-K1.18/22/2025001-38105
3.1Certificate of Amendment of Second Amended and Restated Certificate of Incorporation of 180 Life Sciences Corp., filed with the Secretary of State of Delaware on July 24, 2025 (increasing authorized shares of common stock to 1,000,000,000 shares)8-K3.17/24/2025001-38105
3.2Certificate of Amendment to the Second Amended and Restated Certificate of Incorporation of 180 Life Sciences Corp. as filed with the Secretary of State of Delaware on August 12, 2025, and effective on August 18, 2025 (Name change to ETHZilla Corporation)8-K3.18/13/2025001-38105
3.3Certificate of Amendment of Second Amended and Restated Certificate of Incorporation for ETHZilla Corporation increasing the Company’s Authorized Number of Shares of Common Stock From One Billion (1,000,000,000) to Five Billion (5,000,000,000), as filed with the Secretary of State of Delaware on October 8, 20258-K3.110/8/2025001-38105
3.4Certificate of Amendment of Second Amended and Restated Certificate of Incorporation of ETHZilla Corporation, filed with the Secretary of State of Delaware on October 14, 2025 (affecting a 1-for-10 Reverse Stock Split)8-K3.110/15/2025001-38105
3.5Third Amended and Restated Bylaws of ETHZilla Corporation effective August 18, 20258-K3.28/13/2025001-38105
4.1Form of Pre-Funded Warrant to Purchase Common Stock of 180 Life Sciences Corp.8-K4.17/30/2025001-38105
4.2Form of Strategic Advisor Warrant to Purchase Common Stock of 180 Life Sciences Corp.8-K4.28/5/2025001-38105
4.3Amendment, dated as of July 28, 2025, to the Securities Purchase Agreement, dated as of February 19, 2021, between 180 Life Sciences Corp. and the purchasers set forth therein8-K4.37/30/2025001-38105
4.4Amendment, dated as of July 28, 2025, to the Securities Purchase Agreement, dated as of August 19, 2021, between 180 Life Sciences Corp. and the purchasers set forth therein8-K4.47/30/2025001-38105
4.5Form of Subsequent Strategic Advisor Warrant to Purchase Common Stock of 180 Life Sciences Corp.8-K4.18/11/2025001-38105
Form of Convertible Debenture dated August 8, 20258-K4.28/11/2025001-38105
4.7Form of Convertible Debenture dated September 23, 20258-K/A4.19/25/2025001-38105
10.1#First Amendment to Executive Consulting Agreement entered into on July 12, 2025 and effective July 31, 2025, by and between 180 Life Sciences Corp., Eric Van Lent and EVL Consulting, LLC8-K10.57/14/2025001-38105
10.2#Fourth Amendment to 180 Life Sciences Corp. 2022 Omnibus Incentive Plan8-K10.17/24/2025001-38105
10.3#Fourth Amended and Restated 180 Life Sciences Corp. 2022 Omnibus Incentive Plan8-K10.27/24/2025001-38105
10.4#180 Life Sciences Corp. 2025 Option Incentive Plan8-K10.26/18/2025001-38105
10.5£Form of Securities Purchase Agreement, dated as of July 29, 2025, between 180 Life Sciences Corp. and the purchasers set forth therein8-K10.58/5/2025001-38105
10.6Form of Registration Rights Agreement, dated as of August 4, 2025, between 180 Life Sciences Corp. and the other parties thereto8-K10.68/5/2025001-38105
10.7Form of Strategic Advisor Agreement, dated as of July 29, 2025, between 180 Life Sciences Corp. and the other parties thereto8-K10.78/5/2025001-38105
10.8£Form of Secured Convertible Debenture Purchase Agreement, dated as of August 8 2025 by and between the Company and the investor thereto8-K10.18/11/2025001-38105
10.9#180 Life Sciences Corp. 2025 Supplemental Option Incentive Plan8-K10.47/30/2025001-38105
10.10#2025 Supplemental Option Incentive Plan – Form of Stock Option Agreement (July 2025 Awards)8-K10.57/30/2025001-38105
10.11#First Amendment to Amended and Restated Executive Consulting Agreement dated July 29, 2025, by and between 180 Life Sciences Corp., Blair Jordan and Blair Jordan Strategy and Finance Consulting Inc.8-K10.67/30/2025001-38105
10.12#Offer Letter dated July 21, 2025, between 180 Life Sciences Corp. and McAndrew Rudisill8-K10.17/30/2025001-38105
10.13£Asset Management Agreement, dated as of August 4, 2025, between 180 Life Sciences Corp. and Electric Treasury Edge, LLC8-K4.28/5/2025001-38105
10.14#Offer Letter effective August 4, 2025, between 180 Life Sciences Corp. and Crystal Heter8-K10.28/5/2025001-38105
10.15#Offer Letter effective August 4, 2025, between 180 Life Sciences Corp. and Andrew Suckling8-K10.38/5/2025001-38105
10.16£Form of Secured Convertible Debenture Purchase Agreement, dated as of August 8 2025 by and between the Company and the investor thereto8-K10.18/11/2025001-38105
10.17£Form of Registration Rights Agreement dated August 8, 20258-K10.28/11/2025001-38105
10.18£Form of Pledge and Security Agreement dated August 8,20258-K10.38/11/2025001-38105
10.19£Form of Guaranty dated August 8, 20258-K10.48/11/2025001-38105
10.20#Form of 180 Life Sciences Corp. 2025 Second Supplemental Option Incentive Plan8-K10.68/11/2025001-38105
10.21#2025 Second Supplemental Option Incentive Plan – Form of Stock Option Agreement (August 2025 Awards)8-K10.78/11/2025001-38105
10.22#Separation and Release Agreement dated September 4, 2025, by and between ETHZilla Corporation, Blair Jordan and Blair Jordan Strategy and Finance Consulting, Inc.8-K10.19/5/2025001-38105
10.23£Amended and Restated Asset Management Agreement, dated as of September 5, 2025, between ETHZilla Corporation and Electric Treasury Edge, LLC8-K10.19/8/2025001-38105
10.24£Physically-Settled Spot and Forward Transaction Agreement between Cumberland DRW LLC and 180 SPV Treasury Vehicle I LLC8-K10.29/8/2025001-38105
10.25#Consulting Agreement dated September 15, 2025, between ETHZilla Corporation and Stephen Shoemaker8-K10.19/19/2025001-38105
10.26#First Amendment to Option Agreement dated September 15, 2025, between ETHZilla Corporation and Stephen Shoemaker8-K10.29/19/2025001-38105
10.27#Executive Employment Agreement dated September 15, 2025, between ETHZilla Corporation and McAndrew Rudisill8-K10.39/19/2025001-38105
10.28£Form of Amendment and Waiver Agreement dated September 22, 20258-K10.29/22/2025001-38105
10.29#ETHZilla Corporation 2025 Omnibus Incentive Plan8-K10.710/8/2025001-38105
10.30Purchase and Subscription Agreement dated October 22, 2025, by and among ETHZilla Corporation and Satschel, Inc.8-K2.110/23/25001-38105
10.32*#Form of Notice of Restricted Stock Grant and Restricted Stock Agreement (November 2025 Grants)X
10.33*#Offer Letter between John Saunders and ETHZilla Corporation dated August 1, 20258-K10.111/14/25001-38105
10.34*Amended and Restated Sales Agreement, dated November 14, 2025, by and between ETHZilla Corporation and Clear Street LLC and TCBI Securities, Inc., d/b/a Texas Capital SecuritiesX
31.1*Certification of Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley ActX
31.2*Certification of Principal Accounting Officer pursuant to Section 302 of the Sarbanes-Oxley ActX
32.1**Certification of Principal Executive Officer Pursuant to Section 906 of the Sarbanes-Oxley ActX
32.2**Certification of Principal Accounting Officer Pursuant to Section 906 of the Sarbanes-Oxley ActX
101.INS*Inline XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document*X
101.SCH*Inline XBRL Taxonomy Extension Schema DocumentX
101.CAL*Inline XBRL Taxonomy Extension Calculation Linkbase DocumentX
101.DEF*Inline XBRL Taxonomy Extension Definition Linkbase DocumentX
101.LAB*Inline XBRL Taxonomy Extension Label Linkbase DocumentX
101.PRE*Inline XBRL Taxonomy Extension Presentation Linkbase DocumentX
104*Inline XBRL for the cover page of this Quarterly Report on Form 10-Q, included in the Exhibit 101 Inline XBRL Document SetX
*Filed herewith.
**Furnished herewith.
£Certain schedules and exhibits have been omitted pursuant to Item 601(b)(2)(ii) of Regulation S-K. A copy of any omitted schedule or Exhibit will be furnished supplementally to the Securities and Exchange Commission upon request; provided, however that ETHZilla Corporation. may request confidential treatment pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended, for any schedule or Exhibit so furnished.
#Indicates management contract or compensatory plan or arrangement.

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

ETHZILLA CORPORATION
Date: November 14, 2025By:/s/ McAndrew Rudisill
McAndrew Rudisill
Chief Executive Officer
(Principal Executive Officer)
Date: November 14, 2025By:/s/ Eric R. Van Lent
Eric R. Van Lent
Chief Accounting Officer
(Principal Financial and Accounting Officer)
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.